Skip to content

Effectivity of the Austrian Disease Management Programme for diabetes regarding metabolic control and risk profile

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN27414162
Enrollment
1200
Registered
2007-07-12
Start date
2007-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type two Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

The Austrian Disease Management Programme for Diabetes involves the following: Structured care: Physicians are encouraged to use standard documentation and a checklist of control examinations that
four modules of 135 minutes each on the following topics: 2.1. General information about diabetes 2.2. Methods of metabolic control (glucose self-control) 2.3. Medication for diabetes 2.4. Nutrition/
information about the DMP. The DMP will be run for one year for the randomised trial, however continuation is planned.

Sponsors

Salzburg Public Health Insurance (Salzburger Gebietskrankenkasse [SGKK]) (Austria)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with diabetes mellitus type two (American Diabetes Association [ADA]/World Health Organisation [WHO] criteria) 2. Aged greater than 18 years

Exclusion criteria

Exclusion criteria: 1. Dementia 2. Psychiatric illness 3. Malignant tumour

Design outcomes

Primary

MeasureTime frame
The following will be assessed at baseline and after one year (i.e. at the end of the trial): 1. HbA1c 2. Number of days hospitalised 3. Percentage of physical and laboratory examinations according to current guidelines

Secondary

MeasureTime frame
The following will be assessed at baseline and after one year (i.e. at the end of the trial): 1. Cardiovascular risk profile 2. Weight reduction 3. Smoking cessation 4. Improved knowledge about diabetes 5. Improved quality of life (measured using the EuroQoL [EQ-5D] questionnaire) 6. Improved patient satisfaction

Countries

Austria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026